PPARG and colorectal cancer: In addition to providing energy for the colonocytes, butyrate can suppress NF-κB transcription factor activation and interferon gamma and upregulate PPARγ, which thus withstand colorectal cancer and inflammatory bowel diseases [43,44,45,46,47].